Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.

Nature | 2010

Sirtuins are NAD(+)-dependent protein deacetylases. They mediate adaptive responses to a variety of stresses, including calorie restriction and metabolic stress. Sirtuin 3 (SIRT3) is localized in the mitochondrial matrix, where it regulates the acetylation levels of metabolic enzymes, including acetyl coenzyme A synthetase 2 (refs 1, 2). Mice lacking both Sirt3 alleles appear phenotypically normal under basal conditions, but show marked hyperacetylation of several mitochondrial proteins. Here we report that SIRT3 expression is upregulated during fasting in liver and brown adipose tissues. During fasting, livers from mice lacking SIRT3 had higher levels of fatty-acid oxidation intermediate products and triglycerides, associated with decreased levels of fatty-acid oxidation, compared to livers from wild-type mice. Mass spectrometry of mitochondrial proteins shows that long-chain acyl coenzyme A dehydrogenase (LCAD) is hyperacetylated at lysine 42 in the absence of SIRT3. LCAD is deacetylated in wild-type mice under fasted conditions and by SIRT3 in vitro and in vivo; and hyperacetylation of LCAD reduces its enzymatic activity. Mice lacking SIRT3 exhibit hallmarks of fatty-acid oxidation disorders during fasting, including reduced ATP levels and intolerance to cold exposure. These findings identify acetylation as a novel regulatory mechanism for mitochondrial fatty-acid oxidation and demonstrate that SIRT3 modulates mitochondrial intermediary metabolism and fatty-acid use during fasting.

Pubmed ID: 20203611 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK019514-29
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK026743
  • Agency: NIA NIH HHS, United States
    Id: K08 AG022325
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK026743-26A1
  • Agency: NIDDK NIH HHS, United States
    Id: K01 DK076573
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL068758-06A1
  • Agency: NIDDK NIH HHS, United States
    Id: DK59637
  • Agency: NIDDK NIH HHS, United States
    Id: U24 DK059637-01
  • Agency: NHLBI NIH HHS, United States
    Id: P01 HL068758
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK067509-04
  • Agency: NIDDK NIH HHS, United States
    Id: U24 DK059637
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK067509
  • Agency: NIA NIH HHS, United States
    Id: K08 AG022325-01A1
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK019514
  • Agency: Howard Hughes Medical Institute, United States

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


National Mouse Metabolic Phenotyping Centers (tool)

RRID:SCR_008997

The mission is to advance medical and biological research by providing the scientific community with standardized, high quality metabolic and physiologic phenotyping services for mouse models of diabetes, diabetic complications, obesity and related disorders.

View all literature mentions

HEK293T (tool)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions